{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:03:13Z","timestamp":1785416593770,"version":"3.56.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s12928-024-00997-4","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T07:01:56Z","timestamp":1713423716000},"page":"273-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of the efficacy of combined device strategies for long femoropopliteal artery disease"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0435-1372","authenticated-orcid":false,"given":"Shuko","family":"Iwata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riho","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Hosoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Urasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"key":"997_CR1","doi-asserted-by":"publisher","first-page":"e005891","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","volume":"11","author":"PA Schneider","year":"2018","unstructured":"Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, et al. Treatment effect of drug coated balloons is durable to 3years in the femoropopliteal arteries: long term results of the INPACT SFA Randomized Trial. Circ Cardiovasc Interv. 2018;11:e005891.","journal-title":"Circ Cardiovasc Interv"},{"key":"997_CR2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0140-6736(18)32262-1","volume":"392","author":"WA Gray","year":"2018","unstructured":"Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, et al. A polymer-coated, paclitaxel eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial. Lancet. 2018;392:1541\u201351.","journal-title":"Lancet"},{"key":"997_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/1526602819885652","volume":"27","author":"EJ Armstrong","year":"2020","unstructured":"Armstrong EJ, Jeon-Slaughter H, Kahlon RS, Niazi KA, Shammas NW, Banerjee S. Comparative outcomes of supera interwoven nitinol vs bare nitinol stents for the treatment of femoropopliteal disease: insights from the XLPAD registry. J Endovasc Ther. 2020;27:60\u20135.","journal-title":"J Endovasc Ther"},{"key":"997_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejvs.2013.05.010","volume":"46","author":"JM Davaine","year":"2013","unstructured":"Davaine JM, Qu\u00e9rat J, Guyomarch B, Brennan MA, Costargent A, Chaillou P, et al. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year. Eur J Vasc Endovasc Surg. 2013;46:201\u201312.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"997_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.5551\/jat.47399","volume":"26","author":"T Tsujimura","year":"2019","unstructured":"Tsujimura T, Takahara M, Iida O, Hiramori S, Hayakawa N, Karashima E, et al. One-year clinical outcomes following implantation of InnovaTM self-expanding nitinol stents in patients with peripheral artery diseases presenting femoropopliteal artery lesions. J Atheroscler Thromb. 2019;26:847\u201355.","journal-title":"J Atheroscler Thromb"},{"key":"997_CR6","doi-asserted-by":"crossref","first-page":"152660282311701","DOI":"10.1177\/15266028231170125","volume":"2","author":"AA Gostev","year":"2023","unstructured":"Gostev AA, Osipova OO, Cheban AV, Saaya SB, Rubtsun AA, Ignatenko PV, et al. Treatment of long femoropopliteal occlusive lesions with self-expanding interwoven nitinol stent: 24 month outcomes of the STELLA-SUPERA-SIBERIA register trial. J Endovasc Ther. 2023;2:15266028231170124.","journal-title":"J Endovasc Ther"},{"key":"997_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1177\/15266028221079770","volume":"30","author":"S Giannopoulos","year":"2023","unstructured":"Giannopoulos S, Strobel A, Rudofker E, Kovach C, Kokkosis AA, Armstrong EJ. Outcomes of stented vs nonstented femoropopliteal lesions treated with drug-coated balloon angioplasty. J Endovasc Ther. 2023;30:194\u2013203.","journal-title":"J Endovasc Ther"},{"key":"997_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/1358863X20987894","volume":"26","author":"S Kum","year":"2021","unstructured":"Kum S, Ipema J, Huizing E, Tan YK, Lim D, Lok IY, et al. Outcomes of the paclitaxel-eluting Eluvia stent for long femoropopliteal lesions in Asian patients with predominantly chronic limb-threatening ischemia. Vasc Med. 2021;26:267\u201372.","journal-title":"Vasc Med"},{"key":"997_CR9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans V, Ricco JB, Bartelink MEL, Bj\u00f6rck M, Brodmannet M, Cohnert T, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS) document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by the European Stroke Organization (ESO), the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC), and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39:763\u2013816.","journal-title":"Eur Heart J"},{"key":"997_CR10","first-page":"493","volume":"16","author":"JH Rogers","year":"2004","unstructured":"Rogers JH, Lasala JM. Coronary artery dissection and perforation complicating percutaneous coronary intervention. J Invasive Cardiol. 2004;16:493\u20139.","journal-title":"J Invasive Cardiol"},{"key":"997_CR11","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","volume":"69","author":"MS Conte","year":"2019","unstructured":"Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69:3S-125S.","journal-title":"J Vasc Surg"},{"key":"997_CR12","doi-asserted-by":"publisher","first-page":"E212","DOI":"10.1002\/ccd.25387","volume":"83","author":"KJ Rocha-Singh","year":"2014","unstructured":"Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83:E212\u201320.","journal-title":"Catheter Cardiovasc Interv"},{"key":"997_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.carrev.2017.11.007","volume":"19","author":"H Bhatt","year":"2018","unstructured":"Bhatt H, Kovach R, Janzer S, George JC. SUPERA stent outcomes in Above-The-Knee IntervEntions: Effects of COMPression and ELongation (SAKE-COMPEL) Sub-study. Cardiovasc Revasc Med. 2018;19:512\u20135.","journal-title":"Cardiovasc Revasc Med"},{"key":"997_CR14","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jacc.2014.12.036","volume":"65","author":"MR Patel","year":"2015","unstructured":"Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015;65:931\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"997_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/1526602820948472","volume":"27","author":"O Iida","year":"2020","unstructured":"Iida O, Takahara M, Soga Y, Fujihara M, Kawasaki D, Hirano K, et al. A novel angiographic risk score for femoropopliteal interventions. J Endovasc Ther. 2020;27:967\u201373.","journal-title":"J Endovasc Ther"},{"key":"997_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ejvs.2015.07.018","volume":"50","author":"JM Davaine","year":"2015","unstructured":"Davaine JM, Querat J, Kaladji A, Guyomarch B, Chaillou P, Costargent A, et al. Treatment of TASC C and D femoropoliteal lesions with paclitaxel eluting stents: 12 month results of the STELLA-PTX registry. Eur J Vasc Endovasc Surg. 2015;50:631\u20137.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"997_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12928-022-00873-z","volume":"38","author":"K Suzuki","year":"2023","unstructured":"Suzuki K, Ueshima D, Higashitani M, Yamauchi Y, Hozawa K, Hayakawa N, et al. Two-year results of endovascular therapy for femoropopliteal arterydisease in Japan during the introduction of drug-eluting devices. Cardiovasc Interv Ther. 2023;38:113\u201320.","journal-title":"Cardiovasc Interv Ther"},{"key":"997_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jcin.2022.01.019","volume":"15","author":"O Iida","year":"2022","unstructured":"Iida O, Takahara M, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, et al. 1-Year outcomes of fluoropolymer-based drug-eluting stent in femoropopliteal practice: predictors of restenosis and aneurysmal degeneration. JACC Cardiovasc Interv. 2022;15:630\u20138.","journal-title":"JACC Cardiovasc Interv"},{"key":"997_CR19","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jcin.2018.03.046","volume":"11","author":"T Bisdas","year":"2018","unstructured":"Bisdas T, Beropoulis E, Argyriou A, Torsello G, Stavroulakis K. 1-Year All-comers analysis of the eluvia drug-eluting stent for long femoropopliteal lesions after suboptimal angioplasty. JACC Cardiovasc Interv. 2018;11:957\u201366.","journal-title":"JACC Cardiovasc Interv"},{"key":"997_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/00033197211042685","volume":"73","author":"M Tan","year":"2022","unstructured":"Tan M, Takahara M, Soga Y, Mori S, Tsuchiya T, Mazaki T, et al. Three-year clinical outcomes following implantation of LifeStent self-expanding nitinol stents in patients with femoropopliteal artery lesions. Angiology. 2022;73:244\u201351.","journal-title":"Angiology"},{"key":"997_CR21","doi-asserted-by":"publisher","first-page":"e005654","DOI":"10.1161\/CIRCINTERVENTIONS.117.005654","volume":"11","author":"D Scheinert","year":"2018","unstructured":"Scheinert D, Micari A, Brodmann M, Tepe G, Peeters P, Jaff MR, et al. Drug-coated balloon treatment for femoropopliteal artery disease. Circ Cardiovasc Interv. 2018;11:e005654.","journal-title":"Circ Cardiovasc Interv"},{"key":"997_CR22","doi-asserted-by":"publisher","first-page":"e025677","DOI":"10.1161\/JAHA.122.025677","volume":"12","author":"Y Soga","year":"2023","unstructured":"Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, et al. Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion. J Am Heart Assoc. 2023;12:e025677.","journal-title":"J Am Heart Assoc"},{"issue":"23","key":"997_CR23","first-page":"00561","volume":"S1051\u20130443","author":"M Fujihara","year":"2023","unstructured":"Fujihara M, Takahara M, Iida O, Kawasaki D, Soga Y, Tobita K, et al. Endovascular therapy with interwoven nitinol stent placement after predilation for heavily calcified femoropopliteal artery disease: results of the BURDOCK study. J Vasc Interv Radiol. 2023;S1051\u20130443(23):00561\u20134.","journal-title":"J Vasc Interv Radiol"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-024-00997-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-024-00997-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-024-00997-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T17:09:44Z","timestamp":1718039384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-024-00997-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["997"],"URL":"https:\/\/doi.org\/10.1007\/s12928-024-00997-4","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,18]]},"assertion":[{"value":"3 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}